Product
EMPAGLIFLOZIN
2 clinical trials
2 indications
Indication
Type 2 DiabetesClinical trial
National, Multicenter, Randomized, Double-blind, Triple-dummy, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes MellitusStatus: Not yet recruiting, Estimated PCD: 2026-03-01
Clinical trial
National, Multicenter, Randomized, Double-blind, Triple-dummy, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.Status: Recruiting, Estimated PCD: 2025-04-01